Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 2 of 185
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Noramco buys Drug Product Business Unit from Cambrex

This acquisition will expand the range of services available to Noramco and its subsidiary Purisys’ active pharmaceutical ingredients (API) customers. The services include drug product formulation development, clinical